KCR Residential REIT

Update re publication of Year End Accounts

RNS Number : 3153Y
KCR Residential REIT PLC
31 December 2019

31 December 2019

KCR Residential REIT plc

("KCR" or the "Company")

Year End Accounts


KCR is disappointed to announce that it will be unable to publish its audited annual report and accounts for the year ended 30 June 2019 (the "Accounts") by 31 December 2019 as required by Rule 19 of the AIM Rules for Companies (the "AIM Rules").  The Company is in the process of finalising the audit and the results will be announced, and the Accounts published, as soon as possible.


The delay is procedural having been caused by time-delays during the course of the audit which started later than expected following the closing of the corporate transaction with Torchlight Fund LP.  


Dealings in the Company's ordinary shares will be temporarily suspended under AIM Rule 40 with effect from 7.30 a.m. on 2 January 2020, until such time as the Accounts have been duly published in compliance with AIM Rule 19.


Notwithstanding the temporary suspension of trading in the Company's ordinary shares, the Company will continue to make announcements as and when there are any developments that require disclosure under the AIM Rules. Further announcements will be made as and when appropriate.



  KCR Residential REIT plc

  Dominic White, Chief Executive

[email protected]
+44 20 3793 5236

  Arden Partners plc

  Richard Johnson


+44 20 7614 5900

Notes to Editors:

KCR's objective is to build a substantial residential property portfolio that generates secure income flow for shareholders. The Directors intend that the group will acquire, develop and manage residential property assets in a number of jurisdictions including the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.